The Global Cancer Therapy Market to Witness Tremendous Growth at a CAGR of 9.12% During the Forecast Period (2019–2027) | DelveInsight
November 15, 2022 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The Global Cancer Therapy Market to Witness Tremendous Growth at a CAGR of 9.12% During the Forecast Period (2019–2027) | DelveInsight The global...
Scitech and the Plough Center Announce Manufacturing Agreement
October 20, 2022 09:00 ET
|
SciTech Development
GROSSE POINTE FARMS, Mich., Oct. 20, 2022 (GLOBE NEWSWIRE) -- SciTech Development is pleased to announce that it has signed a $600K manufacturing agreement with The Plough Center for Sterile Drug...
Peptide Therapeutics Market Worth USD 91.25 Billion with Grow at a CAGR of 8.8% from 2022 to 2031 | TMR Study
October 13, 2022 13:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – In 2021, the global peptide therapeutics market size stood at around US$ 39.34 Bn. The...
NKGen Biotech to Present at the Baird 2022 Global Healthcare Conference
September 07, 2022 14:00 ET
|
NKGen Biotech
SANTA ANA, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- NKGen Biotech, a biotechnology company harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell...
NKGen Biotech To Present SNK01 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2022
September 06, 2022 14:37 ET
|
NKGen Biotech
SANTA ANA, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- NKGen Biotech, a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell...
Novel Drug Delivery Systems in Cancer Therapy Market is Expected to Reach US$ 88.5 billion in 2032 - Future Market Insights, Inc.
June 08, 2022 09:00 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, June 08, 2022 (GLOBE NEWSWIRE) -- The novel drug delivery systems in the cancer therapy market are predicted to account for US$ 88.5 billion in 2032, up from US$ 14.8 billion in 2022,...
F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration
January 05, 2022 08:00 ET
|
F-star Therapeutics, Inc.
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next...
F-star Therapeutics to Host Virtual R&D Day on December 6, 2021
November 29, 2021 08:00 ET
|
F-star Therapeutics, Inc.
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Nov. 29, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next...
PEPTOMYC SL Announces Treatment of First Patient with its Lead Compound OMO-103 in a Phase I/II Clinical Trial
May 06, 2021 03:30 ET
|
Peptomyc S.L.
BARCELONA, Spain, May 06, 2021 (GLOBE NEWSWIRE) -- Peptomyc, a Spanish clinical stage biotech company spin-off of the Vall d’Hebron Institute of Oncology (VHIO) and the Catalan Institute of Research...
F-star Therapeutics to Present at Upcoming Investor Conferences
March 04, 2021 08:00 ET
|
F-star Therapeutics, Inc.
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next...